|
PHF20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.992200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.533400E-01 |
| Normal-vs-Stage2 |
6.647600E-01 |
| Normal-vs-Stage3 |
1.177430E-01 |
| Normal-vs-Stage4 |
4.126800E-01 |
| Stage1-vs-Stage2 |
6.608800E-01 |
| Stage1-vs-Stage3 |
1.125230E-01 |
| Stage1-vs-Stage4 |
3.178400E-01 |
| Stage2-vs-Stage3 |
2.911400E-01 |
| Stage2-vs-Stage4 |
5.694200E-01 |
| Stage3-vs-Stage4 |
7.749600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.693610E-01 |
| Normal-vs-AfricanAmerican |
9.447000E-01 |
| Normal-vs-Asian |
9.950800E-01 |
| Caucasian-vs-AfricanAmerican |
3.439000E-01 |
| Caucasian-vs-Asian |
7.244200E-01 |
| AfricanAmerican-vs-Asian |
9.766800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.371800E-01 |
| Normal-vs-Female |
4.922500E-03 |
| Male-vs-Female |
1.958160E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.865400E-01 |
| Normal-vs-Extreme_Weight |
4.784200E-01 |
| Normal-vs-Obese |
2.876000E-02 |
| Normal-vs-Extreme_Obese |
3.608300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.828200E-01 |
| Normal_Weight-vs-Obese |
8.605700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.095600E-01 |
| Extreme_Weight-vs-Obese |
6.844500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.764000E-01 |
| Obese-vs-Extreme_Obese |
3.253800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.529800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.399680E-02 |
| Normal-vs-Age(61-80Yrs) |
5.503400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.842010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.514400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.233850E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.376300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.395900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.203870E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.373000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.731200E-01 |
| Normal-VS-Type2 PRCC |
9.560200E-01 |
| Normal-VS-KIRP CIMP |
1.629410E-01 |
| Normal-VS-Unclassified PRCC |
6.098600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.874000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.105830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.897400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.361630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.040100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.304200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.775200E-01 |
| Normal-vs-N1 |
1.284200E-02 |
| Normal-vs-N2 |
4.990100E-02 |
| N0-vs-N1 |
6.284900E-03 |
| N0-vs-N2 |
2.537400E-01 |
| N1-vs-N2 |
8.105400E-01 |
|
|
